Reset
Showing 16 of 16 academic articles

I do not want to suppress the natural process of inflammation: new insights on factors associated with non-adherence in rheumatoid arthritis

Valentin Ritschl, Angelika Lackner, Carina Boström, Erika Mosor et al. • Arthritis Research & Therapy (2018)

Abstract Background It is estimated that 50–70% of patients with rheumatoid arthritis (RA) are non-adherent to their recommended treatment. Non-adherent patients have a higher risk of not reaching an optimal clinical outcome. We explored fa...

DOAJ Open Access (DOAJ) DOI: 10.1186/s13075-018-1732-7

The Immunomodulatory and Anti-Inflammatory Effect of Curcumin on Immune Cell Populations, Cytokines, and In Vivo Models of Rheumatoid Arthritis

Sebastian Makuch, Kamil Więcek, Marta Woźniak • Pharmaceuticals (2021)

Rheumatoid arthritis (RA) is a widespread chronic autoimmune disorder affecting the joints, causing irreversible cartilage, synovium, and bone degradation. During the course of the disease, many immune and joint cells are activated, causing...

DOAJ Open Access (DOAJ) DOI: 10.3390/ph14040309

Curcumin: Reintroduced Therapeutic Agent from Traditional Medicine for Alcoholic Liver Disease

Hamid Reza Rahimi, Mahmoud Reza Jaafari, Amir Hooshang Mohammadpour, Khalil Abnous et al. • Asia Pacific Journal of Medical Toxicology (2015)

Alcoholic liver disease (ALD) is the main cause of chronic liver disease across the world and can lead to fibrosis and cirrhosis. The etiopathogenesis of ALD is related to ethanol-induced oxidative stress, glutathione reduction, abnormal me...

DOAJ Open Access (DOAJ) DOI: 10.22038/apjmt.2015.3983

Korean Red Ginseng exhibits no significant adverse effect on disease activity in patients with rheumatoid arthritis: a randomized, double-blind, crossover study

Soo-Kyung Cho, Dam Kim, Dasomi Yoo, Eun Jin Jang et al. • Journal of Ginseng Research (2018)

Background: Panax ginseng is a well-known immune modulator, and there is concern that its immune-enhancing effects may negatively affect patients with rheumatoid arthritis (RA) by worsening symptoms or increasing the risk of adverse effects...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.jgr.2017.01.006

Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology

Lisa Argnani, Anna Zanetti, Anna Zanetti, Greta Carrara et al. • Frontiers in Medicine (2021)

Background: Rheumatoid arthritis (RA) is associated with an increase in cardiovascular (CV) risk. This issue maybe not only explained by a genetic component, as well as by the traditional CV risk factors, but also by an underestimation and ...

DOAJ Open Access (DOAJ) DOI: 10.3389/fmed.2021.745601

Worldwide productivity and research trend of publications concerning extracellular vesicles role in fibrosis: A bibliometric study from 2013 to 2022

Ya-Wen Peng, Ri Tang, Qiao-Yi Xu, Shu-Ya Mei et al. • Heliyon (2024)

Background: Fibrosis is a heavy burden on the global healthcare system. Recently, an increasing number of studies have demonstrated that Extracellular vesicles play an important role in intercellular communication under both physiological a...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.heliyon.2024.e24357

Increased remission with fewer corticosteroids and more biologics in rheumatoid arthritis at 7-year follow-up in real-life conditions

Guillaume Larid, Justine Vix, Ronan Garlantezec, Elodie Loppin et al. • Scientific Reports (2022)

Abstract Remission in rheumatoid arthritis (RA) is an important therapeutic target that is not easy to achieve in real-life conditions. Some prognostic factors have been identified but the literature is variable. The objectives of this stud...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-022-06584-y

Prediction of Drug Targets for Specific Diseases Leveraging Gene Perturbation Data: A Machine Learning Approach

Kai Zhao, Yujia Shi, Hon-Cheong So • Pharmaceutics (2022)

Identification of the correct targets is a key element for successful drug development. However, there are limited approaches for predicting drug targets for specific diseases using omics data, and few have leveraged expression profiles fro...

DOAJ Open Access (DOAJ) DOI: 10.3390/pharmaceutics14020234